SCIENSUS
Sciensus is provides health informatics services. The company’s services include consulting, managed entry, EPR development, and strategic and tactical support. It also develops Web centric clinical database applications, as well as primary and secondary care audit programs, collaborative clinical workspaces, patient registries, and various medical software products.
SCIENSUS
Industry:
Consulting Health Care
Founded:
2003-01-01
Address:
Brighton, East Sussex, United Kingdom
Country:
United Kingdom
Website Url:
http://www.sciensus.com
Status:
Active
Contact:
+44 1273 648 580
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.sciensus.com
- Host name: 74.129.242.35.bc.googleusercontent.com
- IP address: 35.242.129.74
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Sciensus"
About Us | Pharma Services & Patient Empowerment
Sciensus is a leading European life sciences organisation with over 30 years of experience. We’re redefining patient-centric care, connecting patients with life-changing medicines while empowering pharmaceutical companies and …See details»
Sciensus - About us | Patient access, engagement and insight
Sciensus is a leading European life sciences organisation with over 30 years of experience. We’re redefining patient-centric care, connecting patients with life-changing medicines while …See details»
Sciensus - Wikipedia
Sciensus (formerly Healthcare at Home) is a global life sciences business established in 1992 by founder and former chairman Charles Walsh based in London. The company supplies a wide range of specialist medications and patient support programmes for chronic, cancer and rare disease patients, with around 1,600 employees dealing with more than 230,000 patients a year. It works with every NHS trust in the UK. See details»
Sciensus - LinkedIn
Sciensus is a life sciences business specialising in patient access, engagement and insight solutions. We proudly sit at the intersection of patients and medicine.See details»
About Sciensus - PharmiWeb.jobs
Apr 30, 2024 Sciensus is a leading pharma services business positioned at the nexus of patient care and medication access. With a distinguished focus on individuals grappling with chronic …See details»
Sciensus - Rare Disease Services - LinkedIn
Sciensus - Rare Disease Services | 1,736 followers on LinkedIn. Sciensus is a life sciences business dedicated to getting rare diseases medicines to hard-to-reach patients in Europe. | …See details»
Sciensus - Crunchbase Company Profile & Funding
Sciensus is provides health informatics services. The company’s services include consulting, managed entry, EPR development, and strategic and tactical support. It also develops Web centric clinical database applications, as well as primary …See details»
Sciensus
Welcome to the Sciensus Portal. If you have already received your login information, please use the Sign In option above. Or, if you would like access to our Portal, then please contact your …See details»
Contact us - Sciensus
About us A leading life sciences organization proudly sitting at the intersection of patients and their medicine. Our locations; Investors; Careers; Leaders with purpose; ... Healthcare …See details»
UK: Christian Tucat succeeds Darryn Gibson as CEO at Sciensus
Oct 17, 2024 Sciensus (formerly Healthcare at Home), a European provider of clinical and pharmaceutical homecare solutions, has appointed Christian Tucat as CEO. He succeeds …See details»
Sciensus - Products, Competitors, Financials, Employees, …
From Sciensus Oct 18 2024 Sciensus, a leading pan-European life sciences business, providing patient access, engagement, and insight solutions, is pleased to announce the appointment of …See details»
Sciensus Company Profile | Management and Employees List
Our organisation is divided into two discrete areas, Sciensus is the health informatics consultancy and provides a number of services including: HI consultancy HI managed entry Patient registry …See details»
Sciensus names Christian Tucat as Chief Executive Officer
Oct 16, 2024 Sciensus, a leading pan European, life sciences business, providing patient access, engagement and insight solutions, is pleased to announce the appointment of …See details»
Sciensus - Rare Disease Services | LinkedIn - LinkedIn Schweiz
Sciensus - Rare Disease Services | 1.740 Follower:innen auf LinkedIn. Sciensus is a life sciences business dedicated to getting rare diseases medicines to hard-to-reach patients in Europe. | …See details»
Sciensus - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Sciensus . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Employee Profiles 2. Number of Board Member and Advisor …See details»
Sciensus - Facebook
Sciensus. 4,275 likes · 1 talking about this. Sciensus is a life sciences business specialising in patient access, engagement and insight solutions. Working in partnership with the NHS, private...See details»
Read Customer Service Reviews of sciensus.com - Trustpilot
Sciensus is a life sciences business specialising in patient access, engagement and insight solutions. In partnership with the NHS, private providers and pharmaceutical companies we …See details»
Rare and Orphan Diseases - Pharmaceutical Services - Sciensus
Step 1. Finding Patients. At Sciensus, we don’t just follow a one-size-fits-all approach. We tailor our strategies to match the unique needs and characteristics of each disease and drug, …See details»
Scientists, Science Supporters and Organizations Ask Congress to …
Jan 13, 2025 Today, in the face of the incoming president's agenda, the Union of Concerned Scientists (UCS) sent a petition signed by 50,588 scientists, experts and science supporters to …See details»
Our Services | Expert Healthcare Solutions - Sciensus
Sciensus connects healthcare professionals and pharmaceutical and biotech companies across life sciences with actionable real-world insights to elevate the patient experience. By enabling …See details»